Back
Hikma Pharmaceuticals PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
43
HKMPF
Hikma Pharmaceuticals PLC
Last Price:
25.07
Seasonality Move:
0.12%
Sell
23
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.82
Seasonality Move:
40.93%
Sell
43
Hikma Pharmaceuticals PLC (HKMPF)
is a Sell
Is Hikma Pharmaceuticals PLC a Buy, Sell or Hold?
- The current Hikma Pharmaceuticals PLC [HKMPF] share price is $25.07. The Score for HKMPF is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- HKMPF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.80. The Score for ADAP is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HKMPF Stock Price Chart
What is Hikma Pharmaceuticals PLC's stock price today?
-
The Hikma Pharmaceuticals PLC share price today is $25.07
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HKMPF is experiencing slight buying pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.80
The current trend is relatively stagnant and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.
HKMPF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 20.33 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.98 - 25.42) | Sell |
| Bollinger Bands (100): | (24.36 - 25.9) | Sell |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 43.52 | Sell |
| Chaikin Money Flow: | 581327 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.76 - 0.92) | Sell |
| Bollinger Bands (100): | (0.87 - 1.21) | Sell |
HKMPF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.07 | Sell |
| 20-day SMA: | 25.1 | Sell |
| 50-day SMA: | 25.52 | Sell |
| 200-day SMA: | 24.63 | Buy |
| 8-day EMA: | 25.08 | Sell |
| 20-day EMA: | 25.16 | Sell |
| 50-day EMA: | 25.25 | Sell |
| 200-day EMA: | 24.69 | Buy |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.74 | Buy |
| 20-day SMA: | 0.82 | Sell |
| 50-day SMA: | 0.98 | Sell |
| 200-day SMA: | 1.13 | Sell |
| 8-day EMA: | 0.76 | Buy |
| 20-day EMA: | 0.81 | Sell |
| 50-day EMA: | 0.92 | Sell |
| 200-day EMA: | 1.04 | Sell |
Hikma Pharmaceuticals PLC Earnings Growth & HKMPF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.
Hikma Pharmaceuticals PLC Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||